Tin tức & Cập nhật
Lọc theo Chuyên ngành:
A3 adenosine receptor agonist safe, effective for treating NAFLD
Namodenoson, an A3 adenosine receptor (A3AR) agonist, shows clinical activity against nonalcoholic fatty liver disease (NAFLD) with or without nonalcoholic steatohepatitis (NASH), according to data from a phase II study.
A3 adenosine receptor agonist safe, effective for treating NAFLD
10 Nov 2021
Dose-reduced ARPI leads to inferior survival in CRPC patients
Reduced-dose treatment with androgen receptor pathway inhibitors (ARPI) lead to poorer oncological outcomes relative to full-dose regimens in castration-resistant prostate cancer (CRPC), a recent study has found.
Dose-reduced ARPI leads to inferior survival in CRPC patients
09 Nov 2021
COVID-19 pandemic has shortened life expectancy in 2020: study
Life expectancy has decreased during the COVID-19 pandemic, with more than 28 million excess life years of life lost in 2020 in 31 countries, according to a study, noting a higher rate in men than women.
COVID-19 pandemic has shortened life expectancy in 2020: study
09 Nov 2021
SG’s COVID-19 lockdown takes toll on older adults’ mental, financial wellbeing
During Singapore’s coronavirus disease 2019 (COVID-19) lockdown, older adults experienced a decrease in depressive symptoms accompanied by growing feelings of loneliness and lower physical activity (PA), according to a recent study.
SG’s COVID-19 lockdown takes toll on older adults’ mental, financial wellbeing
09 Nov 2021
Hydrochlorothiazide use poses risk of cutaneous squamous cell carcinoma among diabetics
Type 2 diabetes (T2D) patients exposed to hydrochlorothiazide for more than 2 years appear to be at higher risk of cutaneous squamous cell carcinoma (cSCC), as reported in a recent study.
